Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists exploit 'trojan horse' feature in SARS-CoV-2 virus to create antivirals against COVID-19

Scientific analysis of a protein enzyme found in COVID-19 could lead to the development of new drugs to treat the virus, research led by Oxford Brookes University scientists has found.

20 Nov 2020

Researchers receive coveted award for outstanding research on COVID-19

The 2020 ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research was presented to a 12-member team for their project "AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics."

20 Nov 2020

Study: More investment is needed to produce, distribute approved COVID-19 vaccines

The success of a COVID-19 vaccine will depend not only on its efficacy but will hinge at least as much on how fast and widely it can be delivered, the severity of the pandemic, and the public's willingness to be immunized, according to a study published in Health Affairs.

20 Nov 2020

Residents of many countries have a positive attitude towards Russian Sputnik V vaccine against coronavirus

The Russian Direct Investment Fund, announces the results of a survey of more than 12,000 respondents in 11 countries on their attitude towards vaccination against coronavirus and their vaccine preferences.

20 Nov 2020

Pork consumption is not likely to cause COVID-19 infection

According to the current state of knowledge, there are no cases that have shown evidence of humans being infected with the novel coronavirus via the consumption of contaminated food.

20 Nov 2020

Multi-institution team receives prestigious award for breakthrough research on SARS-CoV-2

The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.

20 Nov 2020

Researchers solve the mystery of silent hypoxia caused by COVID-19

More than six months since COVID-19 began spreading in the United States, scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body.

19 Nov 2020

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.

19 Nov 2020

Vibrational motions of spike proteins correlate with infectivity and lethality of coronaviruses

When someone struggles to open a lock with a key that doesn't quite seem to work, sometimes jiggling the key a bit will help.

19 Nov 2020

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).

19 Nov 2020

Antibody combinations may be more effective at preventing, treating COVID-19

Pairs of antibodies may be more effective than single antibodies at preventing and treating COVID-19, according to a new study by researchers at the University of North Carolina at Chapel Hill and The Rockefeller University in New York.

19 Nov 2020

Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2

The researchers show that the mice immunized with homotypic or mosaic nanoparticles produced broad binding and neutralizing responses, in contrast to plasma antibodies elicited in humans by SARS-CoV-2 infection. The RBD nanoparticles induced cross-reactive IgG responses in the immunized mice.

19 Nov 2020

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.

19 Nov 2020

Swiss data shows COVID-19 three times more deadly than the flu

Despite this, COVID-19 is often downplayed to be only a seasonal flu by many. This may be because both influenza and COVID-19 have a similar initial presentation, and it is tough to distinguish between the two based on just the clinical presentation.

19 Nov 2020

Cannabis use disorder may increase risk of COVID-19 hospitalization

Researchers in the United States have conducted a study suggesting that genetic vulnerability to a psychiatric syndrome called cannabis use disorder (CUD) may increase the risk of developing severe coronavirus disease 2019 (COVID-19) that requires hospitalization.

19 Nov 2020

New findings support current and planned clinical trials of Janssen SARS-CoV-2 vaccine

Researchers from the United States and The Netherlands have conducted a pre-clinical study supporting the initiation of a Phase 3 trial to test a two-dose regimen of the Janssen Ad26.COV2.S vaccine candidate among adult and elderly individuals.

19 Nov 2020

Study warns elderly individuals less able to reduce contacts during COVID-19 lockdown

In a rigorous medRxiv* preprint paper, a group of researchers demonstrate shifts in age structure and clinical characteristics of individuals affected with coronavirus disease (COVID-19) after social and economic reopening in three US states and show how elderly individuals were less able to reduce contacts when compared to the younger ones.

19 Nov 2020

Seroprevalence meta-analysis predicts 643 million already infected by SARS-CoV-2 globally

A recent systematic review and meta-analysis conducted by a team of international scientists reveal low seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the general population.

19 Nov 2020

Detectable SARS-CoV-2 antibodies 120 days post-infection in Chicago case study

In a recent study, a team of researchers at Northwestern University, USA, had found that nearly 20 percent seroprevalence in the United States metropolitan site, Chicago, over the summer, during a period when lockdown restrictions were eased. They found that three-quarters of seropositive individuals retained detectable antibodies for at least 120 days or four months.

19 Nov 2020

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.

19 Nov 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists exploit 'trojan horse' feature in SARS-CoV-2 virus to create antivirals against COVID-19

Researchers receive coveted award for outstanding research on COVID-19

Study: More investment is needed to produce, distribute approved COVID-19 vaccines

Residents of many countries have a positive attitude towards Russian Sputnik V vaccine against coronavirus

Pork consumption is not likely to cause COVID-19 infection

Multi-institution team receives prestigious award for breakthrough research on SARS-CoV-2

Researchers solve the mystery of silent hypoxia caused by COVID-19

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Vibrational motions of spike proteins correlate with infectivity and lethality of coronaviruses

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Antibody combinations may be more effective at preventing, treating COVID-19

Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Swiss data shows COVID-19 three times more deadly than the flu

Cannabis use disorder may increase risk of COVID-19 hospitalization

New findings support current and planned clinical trials of Janssen SARS-CoV-2 vaccine

Study warns elderly individuals less able to reduce contacts during COVID-19 lockdown

Seroprevalence meta-analysis predicts 643 million already infected by SARS-CoV-2 globally

Detectable SARS-CoV-2 antibodies 120 days post-infection in Chicago case study

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in